Abstracts rules


  1. Category Submission
    • Abstracts can be submitted into 3 categories: Virology/Laboratory, Epidemiology/Public Health and Human-Animal Interface.
    • Abstract must be limited to 300 words divided into Introduction, Methods, Results, and Discussion
  2. Publication
    • Upon submission of an abstract, the author provides consent to allow ANISE to publish the abstract in the onsite 6th ANISE Meeting program book, and posted on the ANISE website 1 month prior to the Meeting
  3. Previous Presentation of Abstracts
    • Abstracts will not be considered for presentation if they have been already published in peer-reviewed journal before January 2017. Abstracts presented or accepted for presentation in a conference in 2017 or published in a peer-reviewed journal in 2017, can be submitted to ANISE 2017.
  4. Informed Consent: 
    • ​​Any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1966:14:103) and must meet all of the requirements governing informed consent of the country in which the study was performed
  5. Use of Animals:
    • All studies involving the use of animals must conform to the 1991 revision of "Guiding Principles in the Care and Use of Animals" (American Physiological Association).
  6. Employees of Commercial Interests
    • ANISE recognizes that employees of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. In order to be compliant with the various continuing medical education regulatory bodies, abstracts submitted by employees of commercial interests should not include patient care recommendations. They should focus on the biology, physiology or physics and include content about the discovery process. Abstracts should avoid discussion of products, treatment or diagnostics. Abstracts from employees of commercial interests that are selected for oral or poster presentation will be subject to additional review prior to ANISE 2017.
  7. Author Disclosure: 
    • ALL abstract authors are required to disclose any conflict of interest.
  8. Co-Author Approval: 
    • Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after September 15, 2017.
  9. Changes to Abstract
    • You are able to resubmit a revised version of your abstract or withdraw until the submission deadline (September 15, 2017). After the submission deadline, only minor abstract changes (author or institution changes, disclosure, keyword or questionnaire updates) are allowed.
  10. Abstract Receipt Confirmation 
    • You will receive an email confirmation within two business days of submitting your abstract. If you submit on the deadline date and do not receive a confirmation within two business days, please contact the organiser (anise@anise-network.org).
  11. Notification of Presentation Status
    • ​​Notifications on oral and poster presentation type will be sent no later than September 30, 2017.